-
Danish Study Suggests Celebrex And Vioxx To Be Avoided After Heart Attack
Increased Risk Of Death For Post-Heart Attack Patients Taking COX-2 Drugs In mid-November 2005 it was reported that Merck’s Vioxx and Pfizer’s Celebrex, as well as some similar painkillers, increase the risk of death…
-
Celebrex and Bextra Federal Court MDL Cases Will Go To California
Product Liability and Sales Claims Assigned To Judge Breyer in San Francisco In Fall 2005 all federal court cases involving Pfizer Inc.’s painkillers Celebrex and Bextra were consolidated into a multi-district litigation (MDL) and…
-
Hormone Replacement Therapy With Alcohol Use Increases Breast Cancer Risk
November 2005 HRT-Alcohol Study Attempts To Find Out More About Mechanism Women who use postmenopausal hormone replacement therapy drugs and, at the same time, use alcohol are apparently at an increased risk of developing…
-
Bayer Has Paid $1.143 Billion To Settle 3,058 Baycol Cases
October 2005 Baycol / Lipobay Settlement Update From Bayer In the first part of November 2005 Bayer AG said that it has paid $1.143 billion to settle 3,058 Baycol / Lipobay cases worldwide. Further,…
-
3600 Hormone Replacement Therapy Drug Lawsuits Filed Since 2002 Study
Do Hormone Drugs Cause Cancer? First Federal Court Trial Set For July On July 9, 2002 a major study of hormone-replacement drugs for menopausal women was halted after finding a possible association between the…
-
AstraZeneca Proposes Early FDA Review For All Prescription Drug Ads
Direct-to-consumer Advertisements Would Be Reviewed Prior To First Use The drug company AstraZeneca Plc has proposed that there be a mandatory FDA review of all direct-to-consumer ("DTC") advertisements for prescription drugs before the ad…
